The novel ginkgolide analog ginkgolide X was characterized functionally at human glycine and ␥-aminobutyric acid type A receptors (GlyRs and GABA A Rs, respectively) in the fluorescence-based FLIPR TM Membrane Potential assay. The compound inhibited the signaling of all GABA A R subtypes included in the study with high nanomolar/low micromolar IC 50 values, except the 1 receptor at which it was a significantly weaker antagonist. Ginkgolide X also displayed high nanomolar/low micromolar IC 50 values at the homomeric ␣1 and ␣2 GlyRs, whereas it was inactive at the heteromeric ␣1 and ␣2 subtypes at concentrations up to 300 M. Thus, the functional properties of the compound were significantly different from those of the naturally occurring ginkgolides A, B, C, J, and M but similar to those of picrotoxin. In a mutagenesis study the 6 M2 residues in the GlyR ion channel were identified as the primary molecular determinant of the selectivity profile of ginkgolide X, and a 6 M2 ring consisting of five Thr residues was found to be of key importance for its activity at the GABA A R. Conformational analysis and docking of low-energy conformations of the native ginkgolide A and ginkgolide X into a ␣1 GlyR homology model revealed two distinct putative binding sites formed by the 6 M2 residues together with the 2 residues and the 10 and 13 residues, respectively. Thus, we propose that the distinct functionalities of ginkgolide X compared with the other ginkgolides could arise from different flexibility and thus different binding modes to the ion channel of the anionic Cys-loop receptor.
␥-Aminobutyric acid (GABA)2 and glycine are the predominant inhibitory neurotransmitters in the central nervous system and also maintain important functions in several peripheral tissues (1-5). The ionotropic GABA A and glycine receptors (GABA A Rs and GlyRs) belong to the Cys-loop receptor superfamily, which also comprises nicotinic acetylcholine receptors (nAChRs) and 5-HT 3 receptors (5-HT 3 Rs) (3-9). The Cys-loop receptors are homomeric or heteromeric assemblies of five subunits, and the pentameric receptor complex consists of three domains: an extracellular domain composed of the N-terminal domains of the five subunits, a transmembrane domain formed by the M1-M4 ␣-helices of the five subunits (including an ion channel predominantly formed by the five M2 helices), and an intracellular domain composed primarily of the large second intracellular loops of the five subunits (4, 7). Signal transduction through the Cys-loop receptor is initiated by binding of the agonist to orthosteric sites situated at the interfaces between the N-terminal domains of the subunits, and this elicits a conformation change in the pentameric complex leading to flux of ions through the ion channel. Whereas nAChRs and 5-HT 3